Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 19.08.2026, 18:46:13
299,45 DKK
Kurs
Kurs
1,05%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 299,45 305 | 299,45 | 305 | 1,853398 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 299,45 | 299,45 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 299,45 285 | 299,45 | 285 | 4,825513 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 299,45 200 | 299,45 | 200 | 33,210887 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 299,45 310 | 299,45 | 310 | 3,523126 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 299,45 285 | 299,45 | 285 | 4,825513 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 299,45 285 | 299,45 | 285 | 4,825513 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 299,45 325 | 299,45 | 325 | 8,532309 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 299,45 305 | 299,45 | 305 | 1,853398 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 299,45 300 | 299,45 | 300 | 0,18367 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 299,45 175 | 299,45 | 175 | 41,559526 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 290 | 299,45 | 290 | 3,155786 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 299,45 | 299,45 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 299,45 300 | 299,45 | 300 | 0,18367 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 299,45 263 | 299,45 | 263 | 12,172316 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 299,45 175 | 299,45 | 175 | 41,559526 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 299,45 300 | 299,45 | 300 | 0,18367 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 275 | 299,45 | 275 | 8,164969 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 299,45 263 | 299,45 | 263 | 12,172316 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 299,45 275 | 299,45 | 275 | 8,164969 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 299,45 300 | 299,45 | 300 | 0,18367 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 299,45 260 | 299,45 | 260 | 13,174153 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 299,45 400 | 299,45 | 400 | 33,578227 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 299,45 400 | 299,45 | 400 | 33,578227 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 299,45 275 | 299,45 | 275 | 8,164969 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 299,45 275 | 299,45 | 275 | 8,164969 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 299,45 250 | 299,45 | 250 | 16,513608 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 299,45 340 | 299,45 | 340 | 13,541493 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 299,45 400 | 299,45 | 400 | 33,578227 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 299,45 275 | 299,45 | 275 | 8,164969 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 299,45 475 | 299,45 | 475 | 58,624144 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 299,45 332 | 299,45 | 332 | 10,869928 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 299,45 390 | 299,45 | 390 | 30,238771 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 299,45 436 | 299,45 | 436 | 45,600267 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 299,45 415 | 299,45 | 415 | 38,58741 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 299,45 270 | 299,45 | 270 | 9,834697 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 299,45 390 | 299,45 | 390 | 30,238771 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 299,45 390 | 299,45 | 390 | 30,238771 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 299,45 360 | 299,45 | 360 | 20,220404 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 299,45 415 | 299,45 | 415 | 38,58741 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 299,45 475 | 299,45 | 475 | 58,624144 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 299,45 350 | 299,45 | 350 | 16,880948 | JPMORGAN |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M